Ethos Financial Group LLC Takes $300,000 Position in Cigna Group $CI

Ethos Financial Group LLC purchased a new position in Cigna Group (NYSE:CI) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 906 shares of the health services provider’s stock, valued at approximately $300,000.

Other hedge funds have also recently bought and sold shares of the company. Flaharty Asset Management LLC acquired a new stake in Cigna Group in the first quarter valued at $28,000. 1248 Management LLC acquired a new position in shares of Cigna Group during the 1st quarter worth $29,000. Solstein Capital LLC purchased a new stake in shares of Cigna Group in the 2nd quarter worth about $29,000. Chilton Capital Management LLC purchased a new stake in shares of Cigna Group in the 2nd quarter worth about $30,000. Finally, Activest Wealth Management grew its stake in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 72 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Stock Up 3.2%

Shares of NYSE CI opened at $264.54 on Friday. The firm has a market cap of $70.66 billion, a P/E ratio of 14.44, a price-to-earnings-growth ratio of 0.88 and a beta of 0.44. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The firm’s 50 day moving average price is $293.24 and its 200 day moving average price is $303.77.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same period in the previous year, the firm posted $7.51 EPS. Cigna Group’s revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be given a dividend of $1.51 per share. The ex-dividend date is Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.3%. Cigna Group’s dividend payout ratio is 26.64%.

Analyst Ratings Changes

A number of brokerages have issued reports on CI. Zacks Research cut shares of Cigna Group from a “hold” rating to a “strong sell” rating in a research report on Monday, November 3rd. Leerink Partners dropped their price objective on shares of Cigna Group from $300.00 to $270.00 in a research note on Friday, October 31st. Truist Financial cut their price objective on Cigna Group from $375.00 to $310.00 in a research report on Friday, October 31st. Guggenheim reduced their target price on Cigna Group from $350.00 to $309.00 in a research note on Friday, October 31st. Finally, Wolfe Research dropped their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, October 15th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $344.91.

Insiders Place Their Bets

In other news, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares in the company, valued at $15,354,600. This represents a 9.49% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 28,526 shares of the firm’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.70% of the stock is owned by corporate insiders.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.